TeleGraft project brings together researchers and practitioners from eleven partner institutions from Denmark, Sweden, Great Britain, Lithuania, Germany, Spain, and Portugal. Read more about the different partners and their role in the project here.
Responsible for arteriovenous graft function, exploitation, regulatory and ethics compliance of the device with relevant medical and diagnostic regulations.
BMD SOFTWARE LDA
Responsible for the development of a software that will display the outcomes of AI modelling to the end-user. Additionally, the monitoring dashboard will be enhanced with technical solutions, enabling remote access for patients and offering standard interfaces to external health information systems.
Klinikum Rechts der Isar der Technischen Universität Munchen
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
Leibniz-Institut für Photonische Technologien
Tasked with the integration of an optical sensor and waveguiding system into arteriovenous grafts, converting raw data into comprehensible outcomes using sophisticated AI modeling techniques.
Region Stockholm
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
Region Syddanmark
Odense University Hospital, a constituent of Region Syddanmark, holds responsibility for the approval of clinical trials and the execution of clinical studies within the Department of Cardiothoracic and Vascular Surgery. Additionally, it oversees matters related to thrombosis and infection within the Department of Clinical Microbiology.
Servicio Vasco de Salud Osakidetza
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
University of Birmingham
Tasked with the role of conducting in vitro evaluations, where all graft components are integrated into a prototype.
University of Southern Denmark
In TeleGraft, SDU is the project coordinator, responsible for efficient project management and transparent financial management, communication, and dissemination but also to define the health economy model.
VERIGRAFT AB
VERIGRAFT AB will develop a biological coating for the adventitial aspect of the graft.
Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
